Canary Speech

Technology

About Our Technology

At the intersection of healthcare and technology.

 

About our technology

Canary speech uses a variety of Machine Learning technologies to solve problems at the intersection of healthcare and technology. We use state of the art automatic speech recognition, natural language processing techniques customized for the problem at hand. Our scientists use everything from linear regression to deep learning and have the freedom to explore various machine learning algorithms to deliver the best results. Our machine learning organization is created and run by scientists and engineers to solve difficult and meaningful problems. 


patented protected

Canary Speech technology is patent protected, with two issued US patent and five additional patents pending in the US and internationally.

  • The first patent is titled, Selecting Speech Features for Building Models for Detecting Medical Conditions (US Patent no. 10,152,988)

  • The second patent is titled, Medical Assessment Based on Voice (US Patent no. 15,973,504)

  • A child patent of the features patent has been filed, Selecting Speech Features for Building Models for Detecting Medical Conditions (16,189,997)

  • The Initial two patents have been filed internationally, the international office has accepted for patenting the Selecting Speech Features for Building Models for Detecting Medical Conditions and all twenty claims.


Smart technology on smart devices

Canary Speech offers a unique opportunity to provide applications in the health and wellness field using smart phones and tablets to provide individualized health information. We work with audio data from call centers, clinic, hospital and human environments.

  • Canary Speech is working on a range of applications in the following areas:

    • Depression

    • Stress

    • Anxiety

    • Tiredness

    • Concussion

    • PTSD

    • Alzheimer’s

    • Parkinson’s

    • Migraine

    • Cancer (quality of life)

    • Others



IMG_4832.HEIC.jpg

anna-demianenko-12400-unsplash.jpg

FDA & IRB Studies

Canary Speech is focusing on opportunities of critical importance. We have successfully completed FDA clinical trials and IRB studies, while providing HIPAA compliant tools, in Alzheimer’s disease, Parkinson’s and depression related to suicide prevention and the treatment of PTSD.